Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 383

    1.

    Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.

    McLennan SV, Martell SK, Yue DK.

    Diabetes. 2002 Aug;51(8):2612-8.PMID: 12145178 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.

    Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ.

    Exp Nephrol. 2001;9(4):249-57.PMID: 11423724 [PubMed - indexed for MEDLINE]Related articles

    3.

    High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: possible role in mesangium accumulation.

    McLennan SV, Martell SY, Yue DK.

    Diabetologia. 2000 May;43(5):642-8.PMID: 10855539 [PubMed - indexed for MEDLINE]Related articles

    4.

    Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.

    McLennan SV, Wang XY, Moreno V, Yue DK, Twigg SM.

    Endocrinology. 2004 Dec;145(12):5646-55. Epub 2004 Sep 2.PMID: 15345671 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.

    McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, Gilbert RE.

    Diabetologia. 2002 Feb;45(2):268-75.PMID: 11935159 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells.

    Anderson SS, Wu K, Nagase H, Stettler-Stevenson WG, Kim Y, Tsilibary EC.

    Cell Adhes Commun. 1996 Aug;4(2):89-101.PMID: 8937745 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy.

    McLennan SV, Fisher E, Martell SY, Death AK, Williams PF, Lyons JG, Yue DK.

    Kidney Int Suppl. 2000 Sep;77:S81-7. Review.PMID: 10997695 [PubMed - indexed for MEDLINE]Related articles

    8.

    An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.

    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.

    Nephrol Dial Transplant. 2006 Sep;21(9):2406-16. Epub 2006 May 25.PMID: 16728425 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.

    Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D, Peehl DM.

    J Cell Physiol. 2002 May;191(2):208-16.PMID: 12064464 [PubMed - indexed for MEDLINE]Related articles

    11.

    Monocyte/mesangial cell interactions in high-glucose co-cultures.

    Menè P, Caenazzo C, Pugliese F, Cinotti GA, D'Angelo A, Garbisa S, Gambaro G.

    Nephrol Dial Transplant. 2001 May;16(5):913-22.PMID: 11328895 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice.

    Kuzuya M, Asai T, Kanda S, Maeda K, Cheng XW, Iguchi A.

    Diabetologia. 2001 Apr;44(4):433-6.PMID: 11357473 [PubMed - indexed for MEDLINE]Related articles

    13.

    Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.

    Shek FW, Benyon RC, Walker FM, McCrudden PR, Pender SL, Williams EJ, Johnson PA, Johnson CD, Bateman AC, Fine DR, Iredale JP.

    Am J Pathol. 2002 May;160(5):1787-98.PMID: 12000730 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.

    Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, Korsten M, Wilson JS, Apte MV.

    Gut. 2003 Feb;52(2):275-82.PMID: 12524413 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.
    17.

    Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.

    Fujiwara M, Muragaki Y, Ooshima A.

    Br J Dermatol. 2005 Aug;153(2):295-300.PMID: 16086739 [PubMed - indexed for MEDLINE]Related articles

    18.

    ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.

    Zhong J, Gencay MM, Bubendorf L, Burgess JK, Parson H, Robinson BW, Tamm M, Black JL, Roth M.

    J Cell Physiol. 2006 May;207(2):540-52.PMID: 16447244 [PubMed - indexed for MEDLINE]Related articles

    19.

    Matrix accumulation in mesangial cells exposed to cyclosporine A requires a permissive genetic background.

    Fornoni A, Lenz O, Tack I, Potier M, Elliot SJ, Striker LJ, Striker GE.

    Transplantation. 2000 Aug 27;70(4):587-93.PMID: 10972214 [PubMed - indexed for MEDLINE]Related articles

    20.

    Alteration in expression of MMP-1 and MMP-2 but not TIMP-1 and TIMP-2 in hereditary gingival fibromatosis is mediated by TGF-beta 1 autocrine stimulation.

    Coletta RD, Almeida OP, Reynolds MA, Sauk JJ.

    J Periodontal Res. 1999 Nov;34(8):457-63.PMID: 10697802 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data